These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 38233485)

  • 21. Development of Oral Care Chip, a novel device for quantitative detection of the oral microbiota associated with periodontal disease.
    Nozawa A; Oshima H; Togawa N; Nozaki T; Murakami S
    PLoS One; 2020; 15(2):e0229485. PubMed ID: 32109938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Horizontal and Vertical Transfer of Oral Microbial Dysbiosis and Periodontal Disease.
    Payne MA; Hashim A; Alsam A; Joseph S; Aduse-Opoku J; Wade WG; Curtis MA
    J Dent Res; 2019 Dec; 98(13):1503-1510. PubMed ID: 31560607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease.
    Jadhav PA; Thomas AB; Nanda RK; Chitlange SS
    Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1324-1333. PubMed ID: 37823422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASSOCIATION BETWEEN PERIODONTITIS AND LIVER DISEASE.
    Rinčić G; Gaćina P; Virović Jukić L; Rinčić N; Božić D; Badovinac A
    Acta Clin Croat; 2022 Feb; 60(3):510-518. PubMed ID: 35282488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impacts of gut microbiota alteration on age-related chronic liver diseases.
    Adhikary S; Esmeeta A; Dey A; Banerjee A; Saha B; Gopan P; Duttaroy AK; Pathak S
    Dig Liver Dis; 2024 Jan; 56(1):112-122. PubMed ID: 37407321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).
    Safari Z; Gérard P
    Cell Mol Life Sci; 2019 Apr; 76(8):1541-1558. PubMed ID: 30683985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
    Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-/- mice brains.
    Poole S; Singhrao SK; Chukkapalli S; Rivera M; Velsko I; Kesavalu L; Crean S
    J Alzheimers Dis; 2015; 43(1):67-80. PubMed ID: 25061055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of pathogenic oral biofilms towards health with nisin probiotic.
    Radaic A; Ye C; Parks B; Gao L; Kuraji R; Malone E; Kamarajan P; Zhan L; Kapila YL
    J Oral Microbiol; 2020 Aug; 12(1):1809302. PubMed ID: 32944159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Distribution of Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola and Aggregatibacter actinomycetemcomitans in Patients with Alcoholic Disease: A Pilot Study.
    Sender-Janeczek A; Ziętek M
    Adv Clin Exp Med; 2016; 25(2):243-8. PubMed ID: 27627556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected lower level of oral periodontal pathogens in patients with high numbers of systemic diseases.
    Shen MT; Shahin B; Chen Z; Adami GR
    PeerJ; 2023; 11():e15502. PubMed ID: 37465146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
    Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
    BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Probiotics (MCP
    Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?
    Harding A; Robinson S; Crean S; Singhrao SK
    J Alzheimers Dis; 2017; 58(2):337-348. PubMed ID: 28453484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periodontopathogens and human β-defensin-2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China.
    Yong X; Chen Y; Tao R; Zeng Q; Liu Z; Jiang L; Ye L; Lin X
    J Periodontal Res; 2015 Jun; 50(3):403-10. PubMed ID: 25065393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates.
    Khan A; Ding Z; Ishaq M; Bacha AS; Khan I; Hanif A; Li W; Guo X
    Int J Biol Sci; 2021; 17(3):818-833. PubMed ID: 33767591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
    Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.